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Abstract The stereospecificity of peptidyl prolyl cis/trans
isomerases (PPIases) was studied using tetrapeptide substrate
analogs in which one amino acid residue was replaced by the
cognate D-amino acid in various positions of the peptide chain.
Reversed stereocenters around proline markedly increased the
rate of the spontaneous trans to cis isomerization of the prolyl
bond whereas cis to trans isomerizations were less sensitive.
PPIases like human cyclophilin18, human FKBP12, Escherichia
coli parvulin10 and the PPIase domain of E. coli trigger factor
exhibited stereoselectivity demanding at the P1 to P2P position of
the substrate chain. The discriminating factor for stereoselectiv-
ity was the lack of formation of the Michaelis complexes of the
diastereomeric substrates. However, D-alanine at the P1 position
preserved considerable affinity to the active site, and largely
prevented activation of the catalytic machinery for all PPIases
investigated.
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1. Introduction
Peptidyl prolyl cis/trans isomerases are enzymes speci¢cally
evolved to catalyze the cis/trans isomerization of prolyl
bonds1. They comprise three families of proteins, cyclophilins,
the FK506-binding proteins (FKBPs) [2] and its related trig-
ger factor [3], and the parvulins [4]. They di¡er in the amino
acid sequence of the catalytic core, the substrate speci¢city
and the sensitivity for inhibitors. For example the immuno-
suppressants cyclosporin A and FK506 selectively inhibit their
partner cyclophilins and FKBPs. PPIases appear to be impor-
tant for a number of cellular processes including folding of
nascent polypeptide chains, transport of proteins [5], viral
replication [6^8], and regulation of the cell cycle [9^12].
They also provide a tool to identify proline-limited rate proc-
esses during the refolding of denatured proteins [13] like
RNase T1 [14], human carbonic anhydrase II [15] and anti-
body Fab fragment [16].
Powerful catalysis up to a di¡usion controlled rate limit for
the bimolecular catalytic constant was frequently observed.
Nevertheless, it is still unclear how PPIases mediate catalysis.
However, it is quite obvious that binding of an aminoacylpro-
lineamide to the active site of PPIases, which completely en-
compasses the P1 and P1P secondary binding sites2, is insu⁄-
cient to liberate even a portion of the catalytic power. On the
other hand a strict requirement for important features of the
P1-P1P moiety, namely the prolyl carbonyl group and some
essential ring system has been noted [17,18], indicating that
extended subsites can only form productive interactions in the
context of an authentic prolyl segment. The positions P2 to
P3P of a substrate were already shown to interact with the
active site of PPIases in a productive manner as shown by
bimolecular rate constants of truncated substrates [2,19]. In
a human Cyp18/oligopeptide complex, in which a 25-mer pep-
tide of the HIV-1 p24 capside protein may represent a seg-
ment of a natural substrate, 12 amino acids could be traced as
an extended backbone supplemented by a 310 helix using the
X-ray structure as a probe for the structure [20]. Nine sub-
strate residues £anking the rotating prolyl bond interacted
with the protein and these secondary binding sites may poten-
tially enhance enzyme catalysis. Quantifying catalysis of pro-
tein folding [21] did not provide the hoped-for insight into the
extension of the catalytically relevant subsites because of the
limited accessibility of the targeted prolyl bond in rapidly
formed folding intermediates.
Once a PPIase is catalytically activated by interactions of
remote subsites various chemical mechanisms are hypothe-
sized to become operative for rate acceleration [2,22^26].
They may act either alone or in combination. The speci¢city
of FKBP12 and E. coli parvulin10 regarding the P1 position
seems to be dependent only on the hydrophobicity of the side
chain of the amino acid preceding proline [4,27,28]. In this
respect Cyp18 has an even more promiscuous substrate char-
acteristics [27]. Contrastingly, the human parvulin-like PPIase
Pin1 and the yeast ESS1 catalyze phosphorylation-dependent
prolyl isomerizations in a highly speci¢c manner for phos-
phoSer/Thr-Pro moieties. Even if enzyme activity of Pin1
has been found for other charged groups at the P1 position
of substrates, full activity of catalysis occurs only for the co-
valently linked dianionic form of the phosphoSer/Thr-Pro mo-
tif. It has been proposed that a kinetically signi¢cant, single
proton dissociation at His59 of Pin1 leads to catalytically ac-
tive enzyme [29]. On the other hand, a cluster of basic amino
acid residues in the S1 site seems to be responsible for the
extraordinary phosphopeptide speci¢city [10,30], which may
be closely related to the cellular substrates of the enzymes.
Evaluating the stereoselectivity of the currently known
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2 Derived nomenclature of subsites according to Schechter and
Berger [1].
*Corresponding author. Fax: (49) (345) 55 11 972.
Abbreviations: Abz, 2-aminobenzoyl residue; CsA, cyclosporin A;
Cyp18, recombinant human cytosolic cyclophilin with molecular mass
of 18 kDa; DMSO, dimethyl sulfoxide; FKBP, FK506 binding
protein; HPLC, high performance liquid chromatography; -NH-Np,
4-nitroanilide; PPIase, peptidyl prolyl cis/trans isomerase; TF domain,
Escherichia coli trigger factor PPIase domain (segment Arg145 to
Glu251); TLC, thin layer chromatography
1 The term prolyl isomerization is used throughout the paper for the
cis/trans isomerization of the peptide bond preceding proline in an
amino acid sequence. Similarly, the term prolyl bond is synonymous
with the peptide bond preceding proline.
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three PPIase families and the FKBP subfamily would identify
not only subsites critically important for approaching the
transition state but may also indicate minor di¡erences in
the activation of the catalytic machinery of the enzyme fam-
ilies. We used a D-amino acid scan from position P2 to P2P of
the common substrate Ala-Ala-Pro-Phe-NH-Np to examine
both enzyme binding and catalysis. We were able to demon-
strate that the marked stereoselectivity for human Cyp18, hu-
man FKBP12, Escherichia coli parvulin10 and E. coli trigger
factor is coupled to di¡erent steps of enzyme catalysis.
2. Materials and methods
2.1. Materials
Subtilisin Carlsberg type VIII was purchased from Sigma Chemical
Co. (St. Louis, MO, USA). Trypsin was a product from Roth (Karls-
ruhe, Germany). Bu¡ers were from Serva (Heidelberg, Germany).
Human recombinant Cyp18 [31], E. coli parvulin10 [32], E. coli trigger
factor domain [33] and human recombinant FKBP12 [34] were puri-
¢ed according to published procedures. Suc-Ala-Ala-Pro-Arg-NH-Np
was purchased from Bachem (Heidelberg, Germany).
2.2. Peptide synthesis
The synthesis of 4-nitroanilide derivatives Phe-NH-Np, D-Phe-NH-
Np and Ala-Ala-Pro-Phe-NH-Np were described previously [35,17].
The tetrapeptide-4-nitroanilides were synthesized using standard pro-
cedures and the corresponding diastereomers were generated in an
analogous manner using the protected amino acid in D-con¢guration
as a building block.
The tert.-butyloxycarbonyl (Boc) moiety was used for temporary
protection of the amino function. The mixed anhydride method (iso-
butylchloroformiate/N-methylmorpholine/THF) was used for the gen-
eration of amide bonds. All compounds were deprotected acidolyti-
cally using 1.3 N HCl in acetic acid. After deprotection of the
tetrapeptide derivatives the products were puri¢ed by preparative
HPLC using di¡erent acetonitrile water mixtures containing 0.1% tri-
£uoroacetic acid as eluent yielding white powders after lyophilization.
All peptides were characterized by ES-MS, 13C- and 1H-NMR spec-
troscopy. The purity of all compounds was checked by TLC, HPLC
and for the deprotected substances by capillary electrophoresis.
2.3. Kinetic studies
2.3.1. Catalytic e⁄ciency of subtilisin. Su⁄ciently high kcat and
kcat/Km values for the subtilisin mediated cleavage of the chromogenic
substrates are the prerequisites for determining prolyl isomerization
rates by isomer-speci¢c proteolysis. Measurements of the initial rates
of 4-nitroanilide cleavage were initiated by addition of protease stock
solution (76 WM, ¢nal concentration 1 WM) to the reaction mixture
containing x Wl peptide stock solution (40 mM, ¢nal concentration
40^70 WM) and y Wl 35 mM HEPES bu¡er pH 7.8 (x+y = 1200 Wl),
and enzyme parameters were evaluated according to Schutkowski et
al. [17]. Except for the peptide Ala-Ala-Pro-D-Phe-NH-Np that has a
very low cleavage rate for the 4-nitroanilide bond, D-Ala-Ala-Pro-Phe-
NH-Np (kcat = 0.4 þ 0.06 s31 ; Km = 474 þ 37 WM), Ala-D-Ala-Pro-Phe-
NH-Np (kcat = 2.6 þ 0.27 s31 ; Km = 3030 þ 410 WM), Ala-Ala-D-Pro-
Phe-NH-Np (kcat = 0.2 þ 0.02 s31 ; Km = 1800 þ 380 WM), Ala-Ala-
Pro-Phe-NH-Np (kcat = 6.4 þ 0.47 s31 ; Km = 581 þ 75 WM) and Abz-
Ala-Ala-Pro-Phe-NH-Np (kcat = 2.8 þ 0.05 s31 ; Km = 16.5 þ 1.2 WM)
met the kinetic criteria of the protease-coupled PPIase assay.
2.3.2. Catalytic constants of PPIases. Using the subtilisin coupled
assay the kinetic constants of the cis/trans isomerization of the peptide
derivatives were measured on a Applied Photophysics stopped-£ow
reaction analyzer at 10‡C. Peptide derivatives were dissolved in 100 Wl
DMSO (2 mM) and diluted with 900 Wl degassed HEPES bu¡er (35
mM) pH 7.8. The enzyme stock solution was prepared by dissolving
22 mg of subtilisin Carlsberg in 200 Wl 1 mM HCl. Finally, the mix-
ture was diluted with reaction bu¡er. The ¢nal concentrations in a
typical assay were 400 WM subtilisin, 10 WM peptide derivatives and
variable concentrations of PPIase in the range of 0.1^5 WM. PPIase
concentration was determined by spectral analysis at 280 nm for
FKBP12, parvulin and TF domain. Concentration of active Cyp18
was determined by £uorimetric titration with cyclosporin A [52].
Determination of the kinetic constants of the cis/trans isomerization
of the peptide containing D-Phe in P2P position was performed using
£uorescence measurements according to Garcia-Echeverria et al. [36].
These measurements were performed on a Hitachi F-3010 £uorescence
spectrophotometer at 10‡C with Abz-Ala-Ala-Pro-Phe-NH-Np and
Abz-Ala-Ala-Pro-D-Phe-NH-Np as substrate and in the presence of
PPIase. Peptide derivatives (10 mM) were dissolved in anhydrous
tri£uoroethanol/0.5 M LiCl. The measurement of the cis/trans isomer-
ization was initiated by addition of the peptide derivative solution to a
mixture of 35 mM HEPES pH 7.8 (¢nal concentration 20 WM) and
the PPIase in concentrations of 0.1^5 WM. Excitation wavelength was
320 nm with a spectral bandwidth of 3 nm. Emission was detected at
416 nm with a spectral bandwidth of 10 nm. Data analysis was per-
formed by single exponential non-linear regression using SigmaPlot
Scienti¢c Graphing System Vers. 2.00 (Jandel Corp., USA). Determi-
nation of the IC50 values was performed according to Schutkowski et
al. [17]. Brie£y, measurements of the rate constant for the PPIase
catalyzed isomerization of Suc-Ala-Ala-Pro-Arg-NH-Np (40 WM) in
the absence and presence of the peptides containing the D-amino acid
(5 concentrations up to 2 mM competing peptide) were performed
using the coupled assay with trypsin as an isomer-speci¢c protease
at 10‡C.
2.4. NMR measurements
All NMR measurements were carried out on a Bruker ARX 500
NMR spectrometer. Spectra were referenced to internal TSP at 0 ppm.
The cis content of the peptides was determined by integration of the
cis and trans signals respectively. For measurement of catalysis we
recorded phase sensitive NOESY spectra to observe the existence or
lack of exchange peaks between the cis and trans conformer. We used
a mixing time of 300 ms for these NOESY experiments. The spectral
width was typically 5050 Hz. As many as 512 t1 increments were
recorded with 32 scans per increment. For the corresponding peptides
a set of three experiments was performed. In the case of Ala-Ala-Pro-
D-Phe-NH-Np the ¢rst EXSY spectrum was measured for the peptide
in solution. After addition of 30 WM cyclophilin a set of exchange
peaks was observable. These exchange peaks disappeared after addi-
tion of CsA. In the case of the peptide containing D-Pro no exchange
peaks were observed after addition of up to 60 WM cyclophilin. After
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Table 1
Thermodynamic equilibrium and kinetic constant of the cis to trans isomerization
D-Amino acid
in position






Ala-Ala-Pro-Phe-NH-Np 10.7b 6.8 þ 0.47 0.81
Abz-Ala-Ala-Pro-Phe-NH-Np 20.1 4.7 þ 0.41 1.18
P2 D-Ala-Ala-Pro-Phe-NH-Np 11.1b 4.4 þ 0.27 0.55
P1 Ala-D-Ala-Pro-Phe-NH-Np 22.5b;c 5.7 þ 0.11 1.65
P1P Ala-Ala-D-Pro-Phe-NH-Np 24.5c 4.5 þ 0.31 1.46
P2P Ala-Ala-Pro-D-Phe-NH-Np 6.5c n.d. n.d.
P2P Abz-Ala-Ala-Pro-D-Phe-NH-Np 16.0c 6.6d 1.26
aError limits are standard deviations of the means of 3 or 4 determinations.
bThe data were obtained using subtilisin as isomer-speci¢c protease according to Fischer et al. [35] in 35 mM HEPES pH 7.8 at 10‡C.
cThe data were obtained using 1H-NMR spectroscopy.
dData are calculated.
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heating of the peptide sample to 42‡C the exchange cross peaks ap-
peared to indicate a faster uncatalyzed prolyl isomerization.
3. Results
After establishing conditions for isomer-speci¢c proteolysis
in the presence of subtilisin comparative studies of diastereo-
meric pairs of tetrapeptides were performed at pH 7.8 and
10‡C. Due to the unfavorable stability of the anilide bond
of Ala-Ala-Pro-D-Phe-NH-Np toward subtilisin and chymo-
trypsin an uncoupled £uorogenic assay was used to measure
directly the cis/trans isomerization rates of Abz-Ala-Ala-Pro-
Phe-NH-Np and Abz-Ala-Ala-Pro-D-Phe-NH-Np. Rate con-
stants of the spontaneous cis to trans isomerization are listed
together with isomer ratios in Table 1. Considerable in£uence
of the chirality of the CK atom on the ratio of prolyl bond
isomers was recognized for the diastereomeric peptides except
for D-alanine in P2 position. Because the cis to trans isomer-
ization rates remained almost constant the reversed trans to
cis direction of rotation proved to be sensitive to CK stereo-
chemistry.
The kinetic consequences of reversing a stereocenter at var-
ious positions of a tetrapeptide substrate was investigated for
the PPIase activity of human recombinant Cyp18, E. coli par-
vulin10, E. coli trigger factor domain and human FKBP12,
each representing the catalytic core of the respective enzyme
family (Table 2).
The incorporation of D-alanine into the P2 position caused
an constantly small decrease of kcat/Km for all examined
PPIases, thus representing the most insensitive position within
the peptides series. An up to 104 fold reduction in kcat/Km was
found for the derivative with D-alanine in P1 position for the
catalysis by Cyp18, parvulin and TF domain. The reduction
for the FKBP12 may be very large because the activity was
below the detection limit of catalysis. Even more detrimental
to enzyme function is D-proline in P1P position, yielding pep-
tides devoid of substrate properties in the measurement limits
(Table 2).
Due to its protease stability described above Ala-Ala-Pro-D-
Phe-NH-Np, which is stereochemically altered in P2P position,
was investigated by 1H-NMR spectroscopy for a qualitative
description of Cyp18 catalysis. As much as 30 WM Cyp18 was
required to produce an additional set of NOESY crosspeaks
indicating its poor substrate nature. Crosspeaks disappeared
after inhibition of Cyp18 enzyme activity by cyclosporin A
[37]. A £uorogenic assay similar to that of Garcia-Echeverria
et al. [36] was performed for derivatives containing an N-ter-
minal 2-aminobenzoyl £uorophore and a C-terminal 4-nitro-
anilide quencher. The £uorescence signal at 416 nm subse-
quent to a solvent jump was evaluated in the time-course in
the presence of PPIases (Fig. 1). In this assay, the D-Phe sub-
stitution at P1P position decreased catalytic e⁄ciency by at
least three orders of magnitude for all PPIases (Table 2).
In order to evaluate whether the stereoselectivity happens at
the formation or interconversion of the Michaelis complexes
both diastereomeric peptides and the reporter all-L substrate
Suc-Ala-Ala-Pro-Arg-NH-Np were allowed to compete for
entry into the active site. Since the diastereomeric peptides
were inert toward 30 WM trypsin, the trypsin-coupled iso-
mer-speci¢c assay was carried out. The a⁄nity of the reporter
substrate for the active site of Cyp18 was indicated by the Km
value of 0.5 mM cis peptide. The IC50 values represent re-
maining enzyme activity, and were calculated from a series
of assays in the presence of 0.2^2 mM concentrations of dia-
stereomeric peptide derivatives (Table 3). In a reference ex-
periment the standard peptide Ala-Ala-Pro-Phe-NH-Np had
an a⁄nity to the active site of the PPIases similar to the
reporter substrate. However, a D-amino acid in P1P or P2P
position prevented from or markedly reduced binding to
PPIases. Only the E. coli trigger factor catalytic domain is




IC50 values of tetrapeptide derivatives interacting with peptidyl prolyl cis/trans isomerases
Tetrapeptide derivative IC50 Cyp18 (WM) IC50 parvulin (WM) IC50 TF domain (WM) IC50 hFKBP12 (WM)
Ala-Ala-Pro-Phe-NH-Np 511 þ 50 274 þ 22 94 þ 7 299 þ 25
D-Ala-Ala-Pro-Phe-NH-Np 664 þ 93 398 þ 47 155 þ 16 137 þ 11
Ala-D-Ala-Pro-Phe-NH-Np 1029 þ 78 362 þ 27 189 þ 12 2620 þ 280
Ala-Ala-D-Pro-Phe-NH-Np a a 681 þ 53 a
Ala-Ala-Pro-D-Phe-NH-Np a 4560 þ 490 2350 þ 190 a
All measurements were obtained using the coupled assay with trypsin as isomer-speci¢c protease and Suc-Ala-Ala-Pro-Arg-NH-Np (40 WM) as
substrate in 35 mM HEPES pH 7.8 at 10‡C.
aThe enzymatic activity was not a¡ected up to ¢nal peptide concentrations of 2 mM.
Table 2
Catalytic e⁄ciency of Cyp18, parvulin, E. coli trigger factor domain and FKBP12
Tetrapeptide derivative kcat/Km (M31s31) kcat/Km (M31s31) kcat/Km (M31s31) kcat/Km (M31s31)
Cyp18 Parvulin TF domain FKBP12
Ala-Ala-Pro-Phe-NH-Np (5.1 þ 0.5)U106 (2.6 þ 0.3)U105 (1.3 þ 0.1)U105 (1.4 þ 0.09)U105
D-Ala-Ala-Pro-Phe-NH-Np (3.4 þ 0.2)U106 (1.1 þ 0.1)U105 (8.4 þ 0.9)U104 (3.3 þ 0.2)U104
Ala-D-Ala-Pro-Phe-NH-Np (1.3 þ 0.1)U102 (1.6 þ 0.09)U103 (2.5 þ 0.09)U102 b
Ala-Ala-D-Pro-Phe-NH-Np b b b b
Abz-Ala-Ala-Pro-Phe-NH-Npa (7.2 þ 0.2)U106 (3.4 þ 0.7)U105 (4.3 þ 0.2)U105 (7.7 þ 1.5)U104
Abz-Ala-Ala-Pro-D-Phe-NH-Npa (2.6 þ 0.4)U103 b b b
All data were obtained using the coupled assay with subtilisin as isomer-speci¢c protease in 35 mM HEPES pH 7.8 at 10‡C.
aData were obtained by using £uorescence measurements in 35 mM HEPES pH 7.8 at 10‡C.
bThe catalytic e⁄ciency was below the detection limit of 100 M31 s31.
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Surprisingly, the P1 stereocenter in D con¢guration which
dramatically inhibits the catalysis retained considerable a⁄n-
ity to the active sites of the PPIases, except for FKBP12 hav-
ing low a⁄nity to Ala-D-Ala-Pro-Phe-NH-Np.
As was already shown in Tables 2 and 3 the chirality of the
P2 position did not contribute much to active site a⁄nity, nor
a¡ects enzymatic activity.
4. Discussion
It is evident from our studies that prolyl cis/trans isomer-
ization of diastereomeric tetrapeptides is sensitive to reversed
stereochemistry at the CK atom in a positional manner. The
altered chirality at P2 position, did not substantially a¡ect
rates of spontaneous rotation or catalysis by PPIases (Tables
1 and 2). We speculate that the remote sites from the prolyl
bond in protein substrates have little e¡ect on catalysis of cis/
trans isomerization.
Positions adjacent to proline were found to be critical for
spontaneous bond rotation. Compared to L-amino acids, D-
amino acids in P1 and P1P position favored the amount of cis
conformer in the equilibrium although both D- and L-amino
acids have similar cis to trans isomerization rates. Therefore
CK chirality a¡ects prolyl isomerizations mainly due to desta-
bilization of the planar trans isomer relative to the twisted
transition state of rotation. In dimethylsulfoxide a similar
preference of the cis conformer has been observed for D-Phe
at the site preceding proline of morphiceptin analogs [38],
whereas the amount of cis conformer is decreased for the D-
amino acid substitutions in charged dipeptides [39].
Positions of reversed chirality shown to be critical for spon-
taneous isomerizations have also been found to exert consid-
erable in£uence on catalysis of prolyl isomerization by
PPIases. In fact, the presence of an amino acid in D con¢g-
uration had markedly detrimental e¡ects on the catalysis by
all PPIase families. The failure of PPIases to utilize a D-Pro
containing peptide could be experimentally attributed to the
lack of formation of the non-covalent enzyme/substrate com-
plex. Only the trigger factor catalytic domain acts as a pro-
miscuous binder for the D-Pro peptide, underlining the special
nature of the trigger factor subfamily of FKBPs [40]. This
¢nding is paralleled by the fact that trigger factor has consid-
erable a⁄nity to proteins lacking proline within their binding
segments. [41]. This ligand promiscuity, originally assigned to
the complementary domains of the full-length protein, can
now be attributed to the catalytic domain as well.
A result that we consider obvious is that reversing the P1
stereocenter did not markedly a¡ect formation of the adsorp-
tive enzyme/peptide complex but greatly reduced or abolished
catalysis. The X-ray structure revealed that binding of Ala-D-
Ala-Pro-Phe-NH-Np to the active site of Cyp18 is similar to
the all-L amino acid congener (Zhao et al., submitted). Thus,
non-speci¢c binding cannot be identi¢ed as the cause of in-
sensitivity to catalytic interconversions. Since -Gly-Pro- pep-
tides can be e¡ectively interconverted by Cyp18 [42] the Ala
side chain methyl preceding proline is not absolutely required
to assist the activation of the catalytic machinery of the
PPIase. Taken together these results point out that a ground
state P1 diastereomeric complex may be resistant to undergo
considerable spatial rearrangements toward of the transition
state due to steric hindrance of the wrongly positioned Ala
side chain. Thus, the pathway toward the enzymatic transition
state has to be considered sterically demanding. Indeed, essen-
tial feature of several mechanisms discussed for PPIase catal-
ysis is the large change of the spatial geometry when isomer-
ization proceeds [22,25,43^45].
Formation of a covalent tetrahedral intermediate nucleo-
philic catalysis belongs to these mechanisms [46]. Recently
the X-ray investigation showed that human Pin1 assembled
a prolyl peptide in a slightly tetrahedral geometry of the prolyl
carbonyl group. Location of nucleophilic side chains adjacent
to the distorted carbonyl supports the hypothesis [30].
Similarly, an electrophilic mechanism assuming stabilization
of deconjugated prolyl bonds by nitrogen protonation or hy-
drogen bond formation [25,47] has been supported by intra-
molecular general acid catalysis of cis/trans isomerization for
the protonated His-Pro moiety in water [48]. In contrast, the
mechanisms of ground state distortion and desolvation by
binding to a hydrophobic cavity [22,27,49] appear to be steri-
cally less restrictive. Therefore only a minor catalytic contri-
bution should be attributed to desolvation of bound sub-
strates. Small catalytic activities found for the P1 D-Ala
substrate with most of the PPIases might indicate this part
of the catalytic machinery, and can be compared quantita-
tively with micellar rate enhancements of the prolyl isomer-
ization [24].
Reminiscent of the e¡ect of P1 position, the reversed stereo-
chemistry in the remote P2P position was found to be rather
deleterious to catalysis, but a⁄nity for the PPIases was low-
ered too. Cyp18 was an exception because catalysis was still
visible but binding was already weak.
Here, analyses become di⁄cult due to the lack of detailed
knowledge about the in£uence of altered P2P position side
chains on PPIase catalysis. Again the peculiarity of the trigger
factor catalytic domain in the context of other FKBPs became
obvious due to the preserved a⁄nity toward the diastereomer-
ic peptide. In the course of a structure-based inhibitor design
Hauske et al. reported that a compound with a D chiral center
at the P2P position has a 17-fold higher a⁄nity to FKBP12
than the compound with the L stereochemistry [50].
The pronounced stereoselectivity of PPIases, following from
our data, is in large contrast to the stereochemical promiscuity
of chaperones which represents the other class of folding help-
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Fig. 1. Time course of £uorescence at 416 nm after jumping from
the peptide stock solution in TFE/LiCl into the ¢nal bu¡er solution
using 20 WM Abz-Ala-Ala-Pro-Phe-NH-Np at 10‡C. A, uncatalyzed
(k = 7.9U103 s31) ; B, 1 nM rhCyp18cy (k = 15.3U103 s31). Meas-
urements were done in 35 mM HEPES pH 7.8, Vex = 320 nm.
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er proteins. Chirality variants on the N-terminal helix in
rhodanese which are represented by an all-D version and an
alternating L and D version bound to GroEL as good as the
protein-derived peptide [51]. In contrast, function of PPIases
sensitively depends on the proper alignment of enzyme and
substrate chains for several interacting sites at the active cen-
ter in order to release catalytic power in a stepwise manner.
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